Journal
ORGANIC LETTERS
Volume 15, Issue 17, Pages 4312-4315Publisher
AMER CHEMICAL SOC
DOI: 10.1021/ol401705a
Keywords
-
Categories
Funding
- ETH [ETH-15 10-2]
- Novartis
- Roche Research Foundation
Ask authors/readers for more resources
Oxetanes are used in drug discovery to enable physicochemical and metabolic property enhancement for the structures to which they are grafted. An imide C=O to oxetane swap on thalidomide and lenalidomide templates provides analogs with similar physicochemical and in vitro properties of the parent drugs, with an important exception: oxetane analog 2 displays a clear differentiation with respect to human plasma stability. The prospect of limiting in vivo stability/metabolism, blocking in vivo racemization, and potentially altering teratogenicity is appealing.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available